small molecule

FEMRING

ESTRADIOL ACETATE

Loss of exclusivity—loss of exclusivity
CompanyMILLICENT MANUFACTURING PR LLC

Drug detail

Brand nameFEMRING
Active ingredientESTRADIOL ACETATE
StrengthEQ 0.05MG BASE/24HR
Dosage formINSERT, EXTENDED RELEASE
RouteVAGINAL
ModalitySmall molecule
FDA approvalMarch 2003
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.